about
Translatability scoring in drug development: eight case studiesA mutation in APP protects against Alzheimer’s disease and age-related cognitive declineFerritin light chain interacts with PEN-2 and affects γ-secretase activityAn overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsInduced pluripotent stem cells for modeling neurological disordersTrafficking regulation of proteins in Alzheimer's diseaseThe potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseThe involvement of microRNAs in neurodegenerative diseasesAxonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cellsSynaptic dysfunction and septin protein family members in neurodegenerative diseasesThe anti-diabetic drug metformin reduces BACE1 protein level by interfering with the MID1 complexHSV-1 and Alzheimer's disease: more than a hypothesis.Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative DiseasesNMR structure of the water soluble Aβ17-34 peptideThe resveratrol trimer miyabenol C inhibits β-secretase activity and β-amyloid generationThe Psen1-L166P-knock-in mutation leads to amyloid deposition in human wild-type amyloid precursor protein YAC transgenic mice.Novel insights into protein misfolding diseases revealed by ion mobility-mass spectrometry.Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's DiseaseAmyloid Precursor Proteins Are Dynamically Trafficked and Processed during Neuronal Development.Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive DimensionsGenetically modified pig models for neurodegenerative disorders.Identification of Risk Pathways and Functional Modules for Coronary Artery Disease Based on Genome-wide SNP Data.Tat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway.Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor.A new DNA vaccine fused with the C3d-p28 induces a Th2 immune response against amyloid-betaAmyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer's diseaseA survey of putative secreted and transmembrane proteins encoded in the C. elegans genomeesyN: network building, sharing and publishingDysregulation of protein trafficking in neurodegeneration.Prophylaxis and treatment of Alzheimer's disease by delivery of an adeno-associated virus encoding a monoclonal antibody targeting the amyloid Beta protein.The γ-secretase complex: from structure to function.APP regulates NGF receptor trafficking and NGF-mediated neuronal differentiation and survival.Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease.Metabotyping of docosahexaenoic acid - treated Alzheimer's disease cell modelReduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 miceNuclear translocation uncovers the amyloid peptide Aβ42 as a regulator of gene transcription.Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-AmyloidIncreasing CREB function in the CA1 region of dorsal hippocampus rescues the spatial memory deficits in a mouse model of Alzheimer's disease.The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.
P2860
Q22241760-AFAB3E53-F925-4585-8B95-05DD9636FC10Q22251083-2997D35B-D1E6-426F-BB84-7B9A8FE655BCQ24293193-8A4950C7-6647-49F6-8784-B511AB3F8A49Q26751302-CAB667DF-76E7-4343-A51C-70009465C03BQ26771402-271C467E-6ACA-49E6-AEEF-D013EC3DA17DQ26825722-DC99ED13-E2AC-4110-94A4-A2B57E1FB58FQ26853347-1CEB0EB9-EDCB-483F-B250-E1FB6D99DEC6Q26858788-CBBA4AD6-D9F1-44D4-955E-8E7949554152Q27022080-C6AC88EA-C56C-4234-BC68-4481B3B44684Q27026829-4971DB8F-1CE3-4515-AFCA-C4B5EDA7F262Q27319458-B45648B3-51E1-45AE-A463-CB6865436DD8Q27692651-4707048E-D258-45AC-B591-DDC40889F37AQ28073686-38D543B7-C3A3-4D3A-8C5C-4D4FDB9AD965Q28382930-AE245158-0230-423B-88F1-02F3B3FD6E15Q28543122-C40DBB1F-789D-4530-8335-B7293A2C925DQ30418483-CEF288B4-C708-49E0-9BB9-30C1114F1B55Q30426229-3220BDE5-C0FA-4A6B-BFE4-9A643B26B787Q30827278-F3441DA5-7D27-43AE-8180-3D75860AC06AQ30829734-F05973DF-387C-482F-A095-CAD54BCB2082Q30998279-B367A1C1-1143-469F-9DDF-88261FCD8AACQ31002975-EF0B5634-7A5C-4E87-922E-616CF471EEC9Q31148631-A46AB0CE-893D-4737-94F3-893446579F63Q33726281-82021385-33A6-4DC4-B29D-6EFFD6ACD249Q33806103-7F7897FE-6C28-4E4D-8BF6-1C22381EF143Q34094661-37E1D68A-6F72-4C27-9674-9B73434873B0Q34217711-492F169C-A7ED-4CFC-B420-4C0CE7F1EB44Q34299120-C344EC9F-721C-4986-A1E9-74CA9D5ED28DQ34348105-B75002DB-32E5-4BDC-939D-9D245BE44713Q34436467-1653DB62-01BB-4343-ADFB-C53E389643A6Q34545170-3B1E3849-010E-49BC-A27A-B30145C4E11EQ34650215-926833F6-1381-4F3B-90AE-DDA52E0AF509Q34677532-00EE5EA6-99BE-4680-9F32-2E09276CD367Q35041654-E94DAAE3-5AB7-450D-96CB-82F89C5CEF0FQ35064974-46A37508-A085-45D2-9210-D5EACD8992C5Q35108713-3F53F4FB-225D-4290-B4A2-A2A12CA95F23Q35137488-45370B31-DCFC-43E9-903A-B9EE8B7F3FFAQ35176787-2B45DCB0-4ACE-4486-94BA-74C93D7A8955Q35210180-CC079439-602E-43CE-B1E2-59DBE941A6FEQ35222767-1EA47B2D-7286-4F4F-BDDD-B72582A237AAQ35599843-2C04F58E-BAC3-466B-8B61-902408528741
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
APP processing in Alzheimer's disease
@ast
APP processing in Alzheimer's disease
@en
APP processing in Alzheimer's disease
@nl
type
label
APP processing in Alzheimer's disease
@ast
APP processing in Alzheimer's disease
@en
APP processing in Alzheimer's disease
@nl
prefLabel
APP processing in Alzheimer's disease
@ast
APP processing in Alzheimer's disease
@en
APP processing in Alzheimer's disease
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
APP processing in Alzheimer's disease
@en
P2093
Robert Thompson
Yun-wu Zhang
P2860
P2888
P3181
P356
10.1186/1756-6606-4-3
P5008
P577
2011-01-07T00:00:00Z
P5875
P6179
1009227363